Raad B. Chowdhury, MD, and Shruti Gupta, MD, MPH, are onconephrologists in the Division of Nephrology at Brigham and Women's Hospital (BWH). They are first and senior authors, respectively, of a paper ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

Jan. 23, 2025 — New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

The study of newer targeted therapies in the treatment of bladder cancer is also discussed, as are future perspectives and a five-year view in the treatment of the disease in patients with renal ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a ...

The main symptom of kidney stones is pain in your back, abdomen, or side. Some other symptoms include cloudy urine, a burning sensation when you urinate, and nausea. Kidney stones are one of the ...

prostate cancer therapy Xtandi (enzalutamide), and Inlyta (axitinib) for kidney cancer. That shift could protect the company from some of the price-cutting measures in the Inflation Reduction Act ...

if someone had bladder cancer. So if the patient had their bladder removed and then developed a renal pelvis tumor a year later, that was an event. So non-urothelial tract recurrence-free survival ...